Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Erikson

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1993
Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral arteryL Bergstrand, U Erikson, I Holme, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) ReportJ Johansson, A G Olsson, L Bergstrand, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1990
Arterial segmental vasoconstriction in hypercholesterolaemic patientsS Nilsson, I Berglund, A Christoffersson, et al.
Journal of Internal Medicine|October 1, 1994
The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemiaL Bergstrand, A G Olsson, U Erikson, et al.
The American Journal of Cardiology|November 1, 1994
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST)G Walldius, U Erikson, A G Olsson, et al.
The American Journal of Cardiology|July 25, 1988
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status reportG Walldius, L A Carlson, U Erikson, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Acta Radiologica (Stockholm, Sweden : 1987)|November 1, 1993
Reproducibility of quantitative arteriographic assessment of atherosclerosis in the femoral arteryL Bergstrand, U Erikson, I Holme, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 1, 1995
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) ReportJ Johansson, A G Olsson, L Bergstrand, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|July 1, 1990
Arterial segmental vasoconstriction in hypercholesterolaemic patientsS Nilsson, I Berglund, A Christoffersson, et al.
Journal of Internal Medicine|October 1, 1994
The relation of coronary and peripheral arterial disease to the severity of femoral atherosclerosis in hypercholesterolaemiaL Bergstrand, A G Olsson, U Erikson, et al.
The American Journal of Cardiology|November 1, 1994
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST)G Walldius, U Erikson, A G Olsson, et al.
The American Journal of Cardiology|July 25, 1988
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status reportG Walldius, L A Carlson, U Erikson, et al.
Pageof 12